919 resultados para epoc® blood analysis system
Resumo:
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Resumo:
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Resumo:
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Resumo:
We investigated the ABO genotypes and heterogeneity of the O alleles in Plasmodium falciparum-infected and non-infected individuals from the Brazilian Amazon region. Sample collection took place from May 2003 to August 2005, from P. falciparum malaria patients from four endemic regions of the Brazilian Amazon. The control group consisted of donors from four blood banks in the same areas. DNA was extracted using the Easy-DNA(TM) extraction kit. ABO genotyping was performed using PCR/RFLP. There was a high frequency of ABO*O01O01. ABO*AO01 was the second most frequent genotype, and the third most frequent genotype was ABO*BO01. There were low frequencies of the ABO*O01O02, ABO*AA, ABO*AB, ABO*BB, and ABO*O02O02 genotypes. We analyzed the alleles of the O phenotype; the O(1variant) allele was the most frequent, both in malaria and non-malaria groups; consequently, the homozygous genotype O(1)(v)O(1)(v) was the most frequently observed. There was no evidence of the homozygous O(2) allele. Significant differences were not detected in the frequency of individuals with the various alleles in the comparison of the malaria patients and the general population (blood donors).
Resumo:
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Resumo:
L'obiettivo di questa tesi è studiare la fattibilità dello studio della produzione associata ttH del bosone di Higgs con due quark top nell'esperimento CMS, e valutare le funzionalità e le caratteristiche della prossima generazione di toolkit per l'analisi distribuita a CMS (CRAB versione 3) per effettuare tale analisi. Nel settore della fisica del quark top, la produzione ttH è particolarmente interessante, soprattutto perchè rappresenta l'unica opportunità di studiare direttamente il vertice t-H senza dover fare assunzioni riguardanti possibili contributi dalla fisica oltre il Modello Standard. La preparazione per questa analisi è cruciale in questo momento, prima dell'inizio del Run-2 dell'LHC nel 2015. Per essere preparati a tale studio, le implicazioni tecniche di effettuare un'analisi completa in un ambito di calcolo distribuito come la Grid non dovrebbero essere sottovalutate. Per questo motivo, vengono presentati e discussi un'analisi dello stesso strumento CRAB3 (disponibile adesso in versione di pre-produzione) e un confronto diretto di prestazioni con CRAB2. Saranno raccolti e documentati inoltre suggerimenti e consigli per un team di analisi che sarà eventualmente coinvolto in questo studio. Nel Capitolo 1 è introdotta la fisica delle alte energie a LHC nell'esperimento CMS. Il Capitolo 2 discute il modello di calcolo di CMS e il sistema di analisi distribuita della Grid. Nel Capitolo 3 viene brevemente presentata la fisica del quark top e del bosone di Higgs. Il Capitolo 4 è dedicato alla preparazione dell'analisi dal punto di vista degli strumenti della Grid (CRAB3 vs CRAB2). Nel capitolo 5 è presentato e discusso uno studio di fattibilità per un'analisi del canale ttH in termini di efficienza di selezione.
Resumo:
Shared Decision Making (SDM) is widely accepted as the preferred method for reaching treatment decisions in the oncology setting including those about clinical trial participation: however, there is some disagreement between researchers over the components of SDM. Specific standardized coding systems are needed to help overcome this difficulty.
Resumo:
Energy transfer between the interacting waves in a distributed Brillouin sensor can result in a distorted measurement of the local Brillouin gain spectrum, leading to systematic errors. It is demonstrated that this depletion effect can be precisely modelled. This has been validated by experimental tests in an excellent quantitative agreement. Strict guidelines can be enunciated from the model to make the impact of depletion negligible, for any type and any length of fiber. (C) 2013 Optical Society of America
Resumo:
INTRODUCTION Despite important advances in psychological and pharmacological treatments of persistent depressive disorders in the past decades, their responses remain typically slow and poor, and differential responses among different modalities of treatments or their combinations are not well understood. Cognitive-Behavioural Analysis System of Psychotherapy (CBASP) is the only psychotherapy that has been specifically designed for chronic depression and has been examined in an increasing number of trials against medications, alone or in combination. When several treatment alternatives are available for a certain condition, network meta-analysis (NMA) provides a powerful tool to examine their relative efficacy by combining all direct and indirect comparisons. Individual participant data (IPD) meta-analysis enables exploration of impacts of individual characteristics that lead to a differentiated approach matching treatments to specific subgroups of patients. METHODS AND ANALYSIS We will search for all randomised controlled trials that compared CBASP, pharmacotherapy or their combination, in the treatment of patients with persistent depressive disorder, in Cochrane CENTRAL, PUBMED, SCOPUS and PsycINFO, supplemented by personal contacts. Individual participant data will be sought from the principal investigators of all the identified trials. Our primary outcomes are depression severity as measured on a continuous observer-rated scale for depression, and dropouts for any reason as a proxy measure of overall treatment acceptability. We will conduct a one-step IPD-NMA to compare CBASP, medications and their combinations, and also carry out a meta-regression to identify their prognostic factors and effect moderators. The model will be fitted in OpenBUGS, using vague priors for all location parameters. For the heterogeneity we will use a half-normal prior on the SD. ETHICS AND DISSEMINATION This study requires no ethical approval. We will publish the findings in a peer-reviewed journal. The study results will contribute to more finely differentiated therapeutics for patients suffering from this chronically disabling disorder. TRIAL REGISTRATION NUMBER CRD42016035886.
Resumo:
Here an inertial sensor-based monitoring system for measuring and analyzing upper limb movements is presented. The final goal is the integration of this motion-tracking device within a portable rehabilitation system for brain injury patients. A set of four inertial sensors mounted on a special garment worn by the patient provides the quaternions representing the patient upper limb’s orientation in space. A kinematic model is built to estimate 3D upper limb motion for accurate therapeutic evaluation. The human upper limb is represented as a kinematic chain of rigid bodies with three joints and six degrees of freedom. Validation of the system has been performed by co-registration of movements with a commercial optoelectronic tracking system. Successful results are shown that exhibit a high correlation among signals provided by both devices and obtained at the Institut Guttmann Neurorehabilitation Hospital.
Resumo:
"August 1994."
Resumo:
Mode of access: Internet.
Resumo:
Bibliography: p. 65-66.